Scarica l'app Stockscreener
5.87
8.28%
-0.53
Dopo l'orario di chiusura:
5.80
-0.07
-1.19%
Precedente Chiudi:
$6.40
Aprire:
$6.21
Volume 24 ore:
100.97K
Relative Volume:
1.72
Capitalizzazione di mercato:
$98.18M
Reddito:
-
Utile/perdita netta:
$-14.88M
Rapporto P/E:
-5.9898
EPS:
-0.98
Flusso di cassa netto:
$-10.29M
1 W Prestazione:
-3.29%
1M Prestazione:
+2.09%
6M Prestazione:
+0.17%
1 anno Prestazione:
-15.78%
Intervallo 1D:
$5.7513
$6.3999
Intervallo di 1 settimana:
$5.7513
$6.84
Portata 52W:
$4.65
$10.24
Coya Therapeutics Inc Stock (COYA) Company Profile
Nome
Coya Therapeutics Inc
Settore
Industria
Telefono
650.739.3939
Indirizzo
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
Confronta COYA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
5.87 | 107.04M | 0 | -14.88M | -10.29M | -0.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-09 | Iniziato | Lake Street | Buy |
| 2024-12-04 | Iniziato | D. Boral Capital | Buy |
Coya Therapeutics Inc Borsa (COYA) Ultime notizie
Merck to discontinue drug from Pandion deal; Coya’s IND for ALS drug is delayed - Endpoints News
Sector ETF performance correlation with Coya Therapeutics Inc.Long Term Stock Planner with Safety Checks - Newser
Is Coya Therapeutics Inc. stock ready for a breakoutRisk Balanced Picks for Safer Trading - Newser
Price action breakdown for Coya Therapeutics Inc.Free Early Breakout Entry Point Notifications - Newser
Buy Signal for Coya Therapeutics Inc. Stock Key Technical Indicators to WatchROI Focused Setup With Drawdown Analysis - Newser
Why Coya Therapeutics Inc. stock attracts strong analyst attentionAI Based High Gain Watchlist Scanner Shared - metal.it
Coya Therapeutics IncFDA unable to meet review goal date for Coya's IND for phase 2 ALS studySEC filing - MarketScreener
How Resilient Is Coya Therapeutics Inc. Stock During Economic DownturnsDaily Chart Pattern Stock Forecast Shows Bullish Setup - metal.it
What makes Coya Therapeutics Inc. stock price move sharplyFree Weekly Return Pick Forecast Reports - Newser
What is Coya Therapeutics Inc. company’s growth strategyStock Strategy Insights For Consistent Profits - jammulinksnews.com
Is it the right time to buy Coya Therapeutics Inc. stockRetirement Planning Updates For Consistent Profits - jammulinksnews.com
Coya Therapeutics Inc. Stock Performance After Earnings: Historical Insights3-Year Equity Summary With Setup Insights - Newser
Why Coya Therapeutics Inc. stock attracts strong analyst attention Sector Rotation and Stock Opportunity Analysis - Newser
How volatile is Coya Therapeutics Inc. stock compared to the marketDiscover high-impact stocks for growth - jammulinksnews.com
How does Coya Therapeutics Inc. compare to its industry peersStrong return on assets - jammulinksnews.com
When is Coya Therapeutics Inc. stock expected to show significant growthInvest confidently with professional advice - jammulinksnews.com
What are the technical indicators suggesting about Coya Therapeutics Inc.Build a diversified portfolio for risk mitigation - jammulinksnews.com
Intrinsic Value of Coya Therapeutics Inc. Stock: Is It Undervalued or OvervaluedStrategic High Profit Opportunities - Newser
Coya Therapeutics Inc. Company Revenue and Profit Trends: A Deep DiveFree Day Trading Recommendations - Newser
How Coya Therapeutics Inc. stock performs during market volatilityOptimized Return Investment Picks - Newser
Coya Therapeutics (NASDAQ:COYA) Earns Buy Rating from D. Boral Capital - Defense World
What drives Coya Therapeutics Inc. stock priceRobust investment performance - PrintWeekIndia
What analysts say about Coya Therapeutics Inc. stockExponential wealth increase - PrintWeekIndia
Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains? - Nasdaq
Coya Therapeutics Announces Publication of Scientific Research Linking Inflammation and Oxidative Stress to the Progression of Parkinson's Disease - MarketScreener
Is Coya Therapeutics Inc. a good long term investmentMarket-crushing stock picks - Autocar Professional
Coya Therapeutics publishes new research study on progression of Parkinson’s - TipRanks
Coya Therapeutics, Inc. Announces Publication of Scientific Research Linking Inflammation and Oxidative Stress to the Progression of Parkinson's Disease - MarketScreener
New Research Reveals Critical Inflammation Pathway in Parkinson's Disease, Potential Treatment Breakthrough - Stock Titan
Rh shares rise 1.14% premarket after Coya Therapeutics to participate in the BTIG Virtual Biotechnology Conference. - AInvest
Coya Therapeutics Inc. Stock Analysis and ForecastBreakout stock performance - jammulinksnews.com
Coya Therapeutics shares rise 4.67% premarket after announcing participation in the BTIG Virtual Biotechnology Conference. - AInvest
Digi Power X Secures $15 Million in Direct Stock Offering - The Globe and Mail
Coya Therapeutics Inc Azioni (COYA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Coya Therapeutics Inc Azioni (COYA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Swaminathan Arun | Chief Executive Officer |
Nov 13 '24 |
Buy |
7.36 |
5,000 |
36,797 |
10,000 |
| Grossman Fred | Chief Medical Officer |
Nov 11 '24 |
Buy |
7.37 |
2,710 |
19,973 |
2,710 |
| Swaminathan Arun | Chief Executive Officer |
Nov 11 '24 |
Buy |
7.34 |
5,000 |
36,689 |
5,000 |
0.23%
0.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):